Capital Intensity
Score how much of a company is physical plant, inventory, and equipment, whether that base is being maintained, and whether the shares have tangible backing.
Thermo Fisher Scientific Inc
Physical assets are 14.5% of total assets, a light footprint. Capex is 0.55x depreciation while free cash flow yield is positive, which can mean an aging base that is still throwing off cash. ROIC is 9.0%, above an 8% cost-of-capital hurdle.
Fixed-asset turnover is 4.22x. Compare it with other names in the same basket.
Physical asset ratio
14.5%
Net PP&E plus inventory, divided by total assets. Above 50% is a heavy footprint.
Fixed asset turnover
4.22x
Revenue per dollar of the physical asset base.
Capex / D&A
0.55x
Above 1.0x means the physical base is being replaced or expanded.
Tangible book / share
-€31.00
Assets minus goodwill, intangibles, and liabilities, per share.
Price / tangible book
—
Price €616.80.
Fixed-charge coverage
2.02x
EBITDA minus capex, divided by interest plus short-term debt.
FCF yield
2.8%
Latest free cash flow divided by current market cap (€228.28B).
ROIC
9.0%
After-tax operating income over equity plus debt minus cash.
Operating income / net PP&E is 0.77x.
Footprint and return
Turnover and reinvestment
| Year | Physical | FAT | Capex/D&A | TBV/sh | Coverage | FCF | ROIC | EBIT/PP&E |
|---|---|---|---|---|---|---|---|---|
| 2018 | 12.8% | 5.85x | 0.33x | -€31.68 | 2.81x | €3.79B | 7.8% | 0.92x |
| 2019 | 15.1% | 4.69x | 0.41x | -€25.21 | 4.51x | €4.05B | 8.4% | 0.77x |
| 2020 | 15.5% | 4.82x | 0.63x | -€10.64 | 2.71x | €6.82B | 15.2% | 1.18x |
| 2021 | 15.7% | 3.98x | 0.97x | -€157.13 | 3.07x | €7.02B | 12.6% | 1.04x |
| 2022 | 17.0% | 4.13x | 0.66x | -€37.11 | 1.54x | €6.91B | 11.1% | 0.78x |
| 2023 | 14.7% | 4.54x | 0.48x | -€35.82 | 1.90x | €6.55B | 9.5% | 0.77x |
| 2024 | 14.7% | 4.61x | 0.45x | -€30.76 | 2.81x | €7.27B | 9.1% | 0.83x |
| 2025 | 14.5% | 4.22x | 0.55x | -€31.00 | 2.02x | €6.29B | 9.0% | 0.77x |
- Principal due is the current portion of debt.
Latest year inputs (2025)
Net PP&E: €10.57B
Inventory: €5.43B
Total assets: €110.34B
Goodwill: €49.36B
Intangibles: €15.84B
Liabilities: €56.81B
Tangible book: -€11.66B
Shares: 376,221,470
Revenue: €44.56B
Capex: €1.53B
D&A: €2.78B
EBITDA: €11.51B
Interest: €1.42B
Short-term debt: €3.53B
Free cash flow: €6.29B
Operating income: €8.11B
Invested capital: €82.94B
Tax rate: 7.5%